North Dakota State Investment Board Takes Position in Danaher Corporation $DHR

North Dakota State Investment Board acquired a new stake in shares of Danaher Corporation (NYSE:DHR) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 21,880 shares of the conglomerate’s stock, valued at approximately $5,009,000.

Other large investors also recently made changes to their positions in the company. Elevated Capital Advisors LLC purchased a new stake in Danaher during the fourth quarter valued at about $26,000. JPL Wealth Management LLC purchased a new stake in Danaher during the third quarter valued at about $25,000. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter valued at about $26,000. ANTIPODES PARTNERS Ltd purchased a new stake in Danaher during the third quarter valued at about $27,000. Finally, Financial Life Planners purchased a new stake in Danaher during the third quarter valued at about $32,000. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 10.80% of the stock is currently owned by company insiders.

Danaher Price Performance

Shares of DHR opened at $161.95 on Monday. The firm has a market cap of $114.62 billion, a PE ratio of 31.32, a PEG ratio of 2.16 and a beta of 0.81. The firm’s 50 day moving average price is $186.30 and its 200 day moving average price is $210.30. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.88 earnings per share. As a group, research analysts expect that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Wall Street Analyst Weigh In

A number of analysts have commented on DHR shares. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. Wolfe Research reduced their price objective on shares of Danaher from $260.00 to $230.00 and set an “outperform” rating for the company in a research note on Wednesday, April 8th. Evercore upped their price objective on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. Finally, Barclays reduced their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research report on Tuesday, April 14th. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average price target of $238.65.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.